Catalyst Wire Dossier Catalyst Wire Dossier

CD33-targeted CAR-T

CD33-targeted chimeric antigen receptor T-cell therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD33-targeted CAR-T, covering 2019-06-25 to 2019-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]

See pricing